Therapy of Clostridium difficile in pseudomembranous and antibiotic-associated colitis.
Panichi
G
G
Department of Internal Medicine III, University of Rome, Italy.
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003015:Clostridium Infections / Q000188:drug therapy* / Q000209:etiology; D003092:Colitis / Q000188:drug therapy* / Q000209:etiology; D006020:Glycopeptides / Q000627:therapeutic use; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use*; D017334:Teicoplanin; D014640:Vancomycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D002792:Cholestyramine Resin; D008795:Metronidazole; D017334:Teicoplanin; D014640:Vancomycin